Skip to main content

Alzheimer's Disease

Beta Blockers May Lower Alzheimer’s Risk
By Emily Lockhart Health Studies in the News

Beta Blockers May Lower Alzheimer’s Risk

If you have blood pressure, migraines, or glaucoma your doctor probably prescribed beta blockers. What you didn’t know is that this medication you’re taking to lower your blood pressure can also reduce your risk of developing dementia. In fact, a recent study from the American Academy of Neurology has found that beta blockers, which are meant to […]

Read More about Beta Blockers May Lower Alzheimer’s Risk

2 min read

Innovative Treatment Could Slow Down Alzheimer’s Disease
By Sponsored Senior

Innovative Treatment Could Slow Down Alzheimer’s Disease

Solanezumab, a new drug created by Eli Lilly has shown promising results in two trails to clear plaques that are believed to be the cause of Alzheimer’s. This is a major achievement for Eli Lilly as there only a few drugs that have been shown to make a difference in delaying this degenerative disease. The […]

Read More about Innovative Treatment Could Slow Down Alzheimer’s Disease

2 min read

Experimental Drug Slows Decline In Alzheimer’s Patients
By Sponsored Senior

Experimental Drug Slows Decline In Alzheimer’s Patients

Combined results from two studies show that Solanezumab, an Alzheimer’s drug being developed by Eli Lilly & Co., might slow mental decline, particularly in milder Alzheimer’s cases. The results were announced on Monday by researchers at a conference of the American Neurological Association in Boston. While the separate studies showed that the drug did not […]

Read More about Experimental Drug Slows Decline In Alzheimer’s Patients

2 min read